Bioymifi,DR5 Activator
10mM in DMSO
- Product Code: 142763
CAS:
1420071-30-2
Molecular Weight: | 494.32 g./mol | Molecular Formula: | C₂₂H₁₂BrN₃O₄S |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20°C |
Product Description:
Bioymifi, DR5 Activator is primarily used in cancer research due to its ability to selectively activate the DR5 (Death Receptor 5) pathway. This activation triggers apoptosis, or programmed cell death, in tumor cells, making it a valuable tool in the development of targeted cancer therapies. It shows particular promise in studies involving resistant cancer cell lines, where conventional treatments fail to induce apoptosis effectively.
The compound enhances the sensitivity of cancer cells to TRAIL (TNF-Related Apoptosis-Inducing Ligand), supporting combination therapies that improve treatment efficacy. It is widely applied in preclinical studies to investigate apoptosis signaling mechanisms and to screen potential anticancer agents. Its role in promoting cancer cell death with minimal effect on normal cells highlights its potential as a selective and efficient therapeutic agent in oncology research.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
1ml | 10-20 days | ฿6,230.00 |
+
-
|
Bioymifi,DR5 Activator
Bioymifi, DR5 Activator is primarily used in cancer research due to its ability to selectively activate the DR5 (Death Receptor 5) pathway. This activation triggers apoptosis, or programmed cell death, in tumor cells, making it a valuable tool in the development of targeted cancer therapies. It shows particular promise in studies involving resistant cancer cell lines, where conventional treatments fail to induce apoptosis effectively.
The compound enhances the sensitivity of cancer cells to TRAIL (TNF-Related Apoptosis-Inducing Ligand), supporting combination therapies that improve treatment efficacy. It is widely applied in preclinical studies to investigate apoptosis signaling mechanisms and to screen potential anticancer agents. Its role in promoting cancer cell death with minimal effect on normal cells highlights its potential as a selective and efficient therapeutic agent in oncology research.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :